--- title: "Labcorp: Competitors" description: "Labcorp compared with companies that share its SEC industry classification: revenue, growth and margins from SEC filings, and how the peer group is chosen." canonical: https://www.getswoopr.com/stocks/companies/labcorp/competitors/ source: "Swoopr Investment: https://www.getswoopr.com" --- # Labcorp: Competitors & Industry Structure ## Direct Answer SEC EDGAR classifies Labcorp under SIC code 8071 (Services-Medical Laboratories). Among Swoopr's S&P 500 Equal Weight companies, 16 others share that classification; by latest reported revenue, Labcorp ranks 1 of 17. A filing classification is a starting point: a company's real competitors depend on its segments, which its 10-K describes. ## How Does Labcorp Compare With Its Peers? | Company | Revenue (latest FY) | Revenue growth | Operating margin | Net margin | | --- | --- | --- | --- | --- | | **Labcorp (LH)** | $14.0 billion FY2025 | 7.2% | 9.9% | 6.3% | | [Quest Diagnostics (DGX)](https://www.getswoopr.com/stocks/companies/quest-diagnostics/) | $11.0 billion FY2025 | 11.8% | 14.1% | 9.0% | | [Natera Inc. (NTRA)](https://www.getswoopr.com/stocks/companies/natera-inc/) | $2.3 billion FY2025 | 35.9% | -13.4% | -9.0% | | [Guardant Health Inc. (GH)](https://www.getswoopr.com/stocks/companies/guardant-health-inc/) | $982 million FY2025 | 32.9% | -44.5% | -42.4% | | [Caris Life Sciences Inc. (CAI)](https://www.getswoopr.com/stocks/companies/caris-life-sciences-inc/) | $812 million FY2025 | 97.0% | 5.6% | -8.4% | | [CareDx Inc. (CDNA)](https://www.getswoopr.com/stocks/companies/caredx-inc/) | $380 million FY2025 | 13.8% | -8.1% | -5.6% | | [Castle Biosciences Inc. (CSTL)](https://www.getswoopr.com/stocks/companies/castle-biosciences-inc/) | $344 million FY2025 | 3.7% | -12.4% | -7.0% | | [Fulgent Genetics Inc. (FLGT)](https://www.getswoopr.com/stocks/companies/fulgent-genetics-inc/) | $323 million FY2025 | 13.8% | -28.2% | -18.8% | | [BillionToOne Inc. (BLLN)](https://www.getswoopr.com/stocks/companies/billiontoone-inc/) | $305 million FY2025 | 100.0% | 5.3% | 2.4% | | [GRAIL Inc. (GRAL)](https://www.getswoopr.com/stocks/companies/grail-inc/) | $147 million FY2025 | 17.2% | -382.0% | -277.5% | | [Biodesix Inc. (BDSX)](https://www.getswoopr.com/stocks/companies/biodesix-inc/) | $88 million FY2025 | 24.1% | -31.5% | -39.9% | | [Personalis Inc. (PSNL)](https://www.getswoopr.com/stocks/companies/personalis-inc/) | $70 million FY2025 | -17.7% | -126.4% | -116.7% | | [Exagen Inc. (XGN)](https://www.getswoopr.com/stocks/companies/exagen-inc/) | $67 million FY2025 | 19.7% | -21.1% | -30.0% | | [American Shared Hospital Services (AMS)](https://www.getswoopr.com/stocks/companies/american-shared-hospital-services/) | $28 million FY2025 | -0.9% | -12.8% | -5.5% | | [YD Bio Limited (YDES)](https://www.getswoopr.com/stocks/companies/yd-bio-limited/) | $596,817 FY2025 | 16.9% | -883.3% | -1392.6% | | [Sera Prognostics Inc. (SERA)](https://www.getswoopr.com/stocks/companies/sera-prognostics-inc/) | $81,000 FY2025 | 5.2% | -45066.7% | -39417.3% | | [Aclarion Inc. (ACON)](https://www.getswoopr.com/stocks/companies/aclarion-inc/) | $75,730 FY2025 | 65.6% | -9312.5% | -9551.9% | Revenue growth compares each company's latest fiscal year with the one before. Fiscal years do not always end on the same date, so treat close comparisons with care. ![Bar chart of operating margin for Labcorp and 7 peers: Labcorp (LH) 9.9%, Quest Diagnostics (DGX) 14.1%, Natera Inc. (NTRA) -13.4%, Guardant Health Inc. (GH) -44.5%, Caris Life Sciences Inc. (CAI) 5.6%, CareDx Inc. (CDNA) -8.1%, Castle Biosciences Inc. (CSTL) -12.4%, Fulgent Genetics Inc. (FLGT) -28.2%.](https://www.getswoopr.com/images/charts/labcorp-competitors-peer-margins.webp) *Operating margin of Labcorp against companies sharing its SEC industry classification, from the table above. Select the chart to open it full size.* ## How Does Labcorp Rank Among All SEC Filers in Its Industry Code? 17 companies with annual reports in Swoopr's SEC dataset share SIC code 8071 (Services-Medical Laboratories), a wider group than the S&P 500 Equal Weight companies above. Ranks run from 1 (highest) and use each company's latest fiscal year, in U.S. dollars. | Measure | Labcorp | Median of filers | Rank | | --- | --- | --- | --- | | Revenue | $14.0 billion | $305 million | 1 of 17 | | Revenue growth | 7.2% | 16.9% | 13 of 17 | | Operating margin | 9.9% | -21.1% | 2 of 17 | | Net margin | 6.3% | -18.8% | 2 of 17 | A SIC code reflects the filer's main business as the SEC records it, so the group mixes companies of very different size; the median is a better guide than the average, and a rank near the top by revenue says nothing about quality. ## Where These Numbers Come From Every figure on this page is a value Labcorp reported in its own SEC filings, read from the SEC's XBRL data (accession 0000920148-26-000111 for fiscal year 2025). Ratios are computed from those reported values. Figures were retrieved on October 7, 2026; a later amendment or a new annual report can change them, and the filing itself always takes precedence over this summary. Each fiscal year is labeled by the calendar year in which it ended, so a company that names the same period differently in its own filings (many retailers whose year ends in January) may use another label. A year is left out of the table when the SEC data set holds no value for it. A figure shown as "Not reported" means the company did not file a value under the standard tag Swoopr reads, not that the amount was zero. This page is educational and describes reported history only; it is not a forecast or a recommendation. ## Frequently Asked Questions ### Who are Labcorp's competitors? Companies sharing Labcorp's SEC classification (SIC code 8071 (Services-Medical Laboratories)) include Quest Diagnostics (DGX), Natera Inc. (NTRA), Guardant Health Inc. (GH), Caris Life Sciences Inc. (CAI), CareDx Inc. (CDNA). Its 10-K names the competitors it considers most relevant. ### How does Labcorp compare with its peers on margins? Labcorp's fiscal 2025 operating margin was 9.9%, against a peer median of -24.7%. ### How are these peers chosen? By the SEC Standard Industrial Classification code each company files under, within Swoopr's S&P 500 Equal Weight company set, falling back to the two-digit major group when fewer than two companies share the exact code. Classification codes are broad, so read the peer list as a screen, not a verdict. ### How does Labcorp rank among all companies in its SEC industry? Among 17 SEC filers under SIC code 8071, Labcorp ranks 1 by latest revenue, and 2 of 17 by operating margin (9.9% against a median of -21.1%). ## References - [SEC EDGAR: LABCORP HOLDINGS INC. Form 10-K filed February 24, 2026](https://www.sec.gov/Archives/edgar/data/920148/000092014826000111/lh-20251231.htm) - [SEC EDGAR: LABCORP HOLDINGS INC. annual and quarterly filings](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=920148&type=10-K) - [SEC: EDGAR application programming interfaces (XBRL frames and submissions data)](https://www.sec.gov/search-filings/edgar-application-programming-interfaces) ## Related Pages - [Labcorp company dossier](https://www.getswoopr.com/stocks/companies/labcorp/) - [Labcorp financial metrics](https://www.getswoopr.com/stocks/companies/labcorp/metrics/) - [Labcorp financial risk indicators](https://www.getswoopr.com/stocks/companies/labcorp/risks/) - [Labcorp peer comparison](https://www.getswoopr.com/stocks/companies/labcorp/competitors/) - [Labcorp business model and revenue mix](https://www.getswoopr.com/stocks/companies/labcorp/business-model/) - [Fundamental analysis guides](https://www.getswoopr.com/learn/fundamental-analysis/) **[Swoopr Editorial Team](https://www.getswoopr.com/authors/swoopr-editorial-team/)** Swoopr's editorial team produces independent investment education content reviewed for accuracy and clarity. We do not provide personalized financial advice. See our [editorial policy](https://www.getswoopr.com/legal/editorial-policy/) and [corrections policy](https://www.getswoopr.com/legal/corrections-policy/).